Obesity-related cardiorenal syndrome

Area of Science:

• Cardiology
• Nephrology
• Pulmonology

Background:

• Obesity cardiomyopathy, characterized by left ventricular hypertrophy and diastolic dysfunction, is linked to right ventricular issues.
• The late stages of obesity cardiomyopathy, particularly cardiorenal syndrome, remain poorly understood.
• Obstructive sleep apnea is frequently observed in obese patients with cardiovascular complications.

Purpose of the Study:

• To investigate the end-stage manifestations of obesity-related cardiovascular disease.
• To describe the progression to cardiorenal syndrome in obese patients experiencing physiologic stress.
• To highlight the spectrum of cardiovascular pathology in obesity, including pulmonary hypertension and diastolic dysfunction.

Main Methods:

• Retrospective study of edematous obese patients with comorbidities.
• Analysis of clinical presentation during physiologic stress or infection.
• Evaluation of cardiorenal parameters, including pulmonary hypertension and renal function.

Main Results:

• Obese patients under severe stress developed pulmonary hypertension and right-sided volume overload.
• Decreased effective arterial blood volume and renal failure were observed.
• Findings were often associated with obstructive sleep apnea, indicating a cardiorenal syndrome.

Conclusions:

• Obesity cardiomyopathy can advance to a critical cardiorenal syndrome.
• Physiologic stress exacerbates cardiovascular and renal dysfunction in obese individuals.
• A broad spectrum of cardiovascular issues, including pulmonary hypertension and sleep apnea, are prevalent in obesity.